Introduction
T-cell lymphoblastic lymphomas account for approximately 29% of non-Hodgkin's lymphomas in children (Sandlund et al., 1996) . They result from malignant thymocytes arising at defined stages of intra-thymic T-cell differentiation and often are clinically aggressive tumours showing great morphological variation. Despite the ever increasing understanding of the molecular pathogenesis and the improvements of treatment outcomes in patients during the past years, essential data about the genetic features remain to be elucidated (Aifantis et al., 2008) . The detection of genetic variants, in particular those with weak phenotypic effects in humans, remains difficult because cancer susceptibility does not, in general, segregate as single Mendelian traits. From such standpoint, working on mouse models has contributed decisively to the identification of tumour susceptibility genes (Balmain, 2002; Mao and Balmain, 2003) .
In the past few years our group has focussed on the identification of new susceptibility genes, starting with a classical model of g-radiation-induced thymic lymphoma (RITL) (Santos et al., 2002) . These lymphomas constitute a heterogeneous group of tumours, with most of them T-cell lymphoblastic lymphomas made up of immature thymocytes (Diamond et al., 1988; Brathwaite et al., 1992) . Genetic loci involved in the susceptibility to RITL have been previously mapped at chromosomes 4, 5, 16 and 19 (Mori et al., 2000; Saito et al., 2001; Ochiai et al., 2003; Kodama et al., 2004; Villa-Morales et al., 2007) . Using inter-specific consomic and congenic mice between the RITL-resistant SEG/Pas (Mus spretus) and RITL-susceptible C57BL/6J strains, we identified a new region of approximately 14 Mb on mouse chromosome 19 that contributes to a significant reduction of the RITL incidence (Tlyr1) (Santos et al., 2002) . Recently, we have shown that the gene encoding the Annexin A1 protein (Anxa1), located at the proximal region of the Tlyr1 region, may act as mediator in the control of RITL development (Santos et al., 2009) . In this work, we further show that the gene encoding the Cd274 antigen, mapped at the distal part of Tlyr1, may be involved in controlling the survival of mice with RITL rather than in inducing significant changes in RITL incidence.
Results

Reduced survival to RITL of Nested Recombinant Haplotype 3 (NRH3) mice
In this study, the first step consisted in analysing the survival of g-treated mice that developed thymic lymphoma (RITL-bearing mice). These mice belonged to three subcongenic strains (NRH1, NRH2 and NRH3), each one of them carrying a non-overlapping chromosome segment from the Tlyr1 region of the resistant SEG/Pas strain (Tlyr1a, Tlyr1b and Tlyr1c, respectively). We showed that the presence of Tlyr1c, but not of any other segment, is able to modify the time between the onset of tumour latency period and death caused by tumourigenesis, with NRH3 mice showing a reduced RITL survival when compared with that of the C57BL/6J mice (Figure 1 ).
The gene encoding the Cd274 antigen is a candidate gene for Tlyr1c Once Tlyr1c was defined, an in silico analysis using the Ensembl database (http://www.ensembl.org) revealed 28 annotated genes mapping to this region. Expression analysis by standard reverse transcriptase-PCR (RT-PCR) revealed 13 of these genes showing expression in the thymus (Supplementary Figure S1) . To further characterize the candidacy of these genes, we determined their expression profiles by quantitative real-time RT-PCR in the thymuses from C57BL/6J and NRH3 mice, both non-treated mice (controls) and those treated with a single sublethal g-ray dose (1.75 Gy). Only the Cd274 gene was overexpressed in early response to g-irradiation (Table 1) .
In the case of thymus, it is well known that Cd274 is broadly expressed in the surface of mouse thymic stromal cells (TSCs) (Liang et al., 2003) . Thus, we analysed the expression patterns of Cd274 in these two cell fractions. Notably, this gene was essentially expressed in TSCs under physiological conditions, and was found to be differentially overexpressed in 1.75 Gy-g-treated TSCs from C57BL/6J and NRH3 mice (Table 2) . To get further insight on the role of Cd274 in RITL development, we examined the expression of this gene in the two cell fractions from the thymuses of RITL-bearing mice as well as in the thymuses of g-treated mice that did not develop thymic lymphoma after the latency period (RITL-free mice). Irrespective of their genotypes, TSCs of RITL-bearing mice showed a strong reduction in the mRNA levels of Cd274 compared with the TSC values observed in nontreated control mice (Table 2) . These results were confirmed by immunofluorescence staining (data not shown). In contrast, no differences were observed in the TSCs from RITL-free mice relative to controls. The transcriptional expression profiles of Cd274 were later confirmed at the protein level (Supplementary Figure  S2) . On the other hand, the analysis of the coding sequence of Cd274 did not reveal any mutation in the tumour samples (data not shown). Given that Cd274 is the natural ligand for Cd279, we also analysed the expression profile of the gene encoding for the Cd279 receptor in the thymus fractions of C57BL/6J and NRH3 mice. No significant differences were found in any of the analysed situations (Supplementary Table S1 ). As Cd274/Cd279 interactions have been described to trigger an inhibitory effect to modulate T-cell receptor (TCR) signalling (Dong et al., 1999) , we analysed the CD69 expression to evaluate TCR signal strength between the two mouse strains (Hare et al., 1999) . Interestingly, flow cytometry analyses showed a significant increase in the number of CD69-positive thymocytes of C57BL/6J after single doses of radiation when compared with that of NRH3 mice (Supplementary Figure S3 ).
Changes in cellularity and reduction in the number of CD4 þ CD8 þ thymocytes in C57BL/6J mice treated with a single sublethal g-ray dose It is known that immature thymocytes, in particular CD4 þ CD8 þ double-positive (DP) cells, readily undergo apoptosis in response to g-radiation (Oka et al., 1999) , and that peripheral T cells can also experience apoptosis when they are stimulated with antigen-presenting cells expressing CD274 (Muhlbauer et al., 2006) . Thus, we wondered whether different levels of Cd274 expression, detected in TSCs of thymuses from 1.75 Gy-treated C57BL/6J and NRH3 mice, could be involved in the promotion of differences in thymocyte cellularity and, specifically, in the number of DP cells. After exposure to g-irradiation, there was a strong decrease in the total number of thymocytes, mainly attributed to the depletion of DP cells, and this reduction was significantly higher in C57BL/6J when compared with that of g-treated NRH3 mice (Figure 2 ). Po0.0001 compared with the corresponding value of the RNA expression of 1.75 Gy-g-treated C57BL/6J mice. To test whether differences in thymocyte cellularity could be attributed to a protective effect against apoptosis, we studied the apoptotic rate using TdTmediated dUTP nick end labeling (TUNEL) assay and flow cytometry. The treatment with 1.75 Gy significantly induced more thymocyte apoptosis in C57BL/6J than in NRH3 mice (Figure 3) . To obtain an additional molecular explanation for the resistance found in the NRH3 mice, we determined the expression level of the pro-apoptotic Bax gene by quantitative real-time RT-PCR. As expected, Bax was overexpressed in response to g-radiation and there existed significant differences between C57BL/ 6J and NRH3 mouse strains (Supplementary Figure S4) .
Ability of the Cd274 antigen to interact with its receptor
Cd279 is stronger in the C57BL/6J genotype A comparative analysis of the coding sequence of Cd274 between both strains revealed seven non-conservative single-nucleotide polymorphisms at codons 6, 17, 115, 215 233, 261 and 284 (GenkBank accession numbers GQ904196 and GQ904197) that resulted in amino acid variation in the Cd274 protein (Supplementary Figure S5) .
To assess the functionality of these polymorphisms, we evaluated the affinity of the C57BL/6J-and NRH3-derived Cd274 ligands for its common receptor Cd279. Using human embryonic kidney (HEK) cells transiently coexpressing Cd274 and Cd279, derived from either C57BL/6J or SEG/Pas, we performed co-immunoprecipitation assays for each of the possible combinations (Figure 4 ). The differences found in the amount of coprecipitates in these assays indicated that the interaction was stronger in cells coexpressing C57BL/6J-derived Cd274 and Cd279 when compared with those resembling the NRH3 genotype (Figure 4 ). This result is in line with previous studies reporting the existence of Cd274 protein variants generated by site-directed mutagenesis with distinct binding capacity for the Cd279 receptor (Wang et al., 2003b) .
Cd274 polymorphisms induce a differential rate of thymocyte apoptosis
To confirm the functional consequences of Cd274 polymorphisms inducing differential rate of thymocyte 
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Figure 2 Flow cytometry analysis of the expression of CD4 and CD8 surface antigens in thymocytes of C57BL/6J and NRH3 mice treated with a single sublethal 1.75 Gy g-ray dose. DP,
B6, C57BL/6J; N3, NRH3. Quantitative data above the representative plots show mean absolute values ± s.d. of three independent experiments, using a minimum of three samples for each experimental category. Significant differences were determined either by a one-way (1) or two-way (2) analysis of variance (ANOVA) test. A T-cell lymphoblastic lymphoma modifier role for Cd274 J Santos et al apoptosis, and to evaluate the consequences of the absence of Cd274 ligand, we generated stably transfected HEK 293 cells expressing the complementary DNA (cDNA) of Cd274 from C57BL/6J and NRH3 mice, and performed co-cultures of transfected or nontransfected HEK cells and thymocytes from C57BL/6J mice. We then analysed the induction of thymocyte apoptosis using TUNEL assays. A significant increase in the rate of thymocyte apoptosis was only observed when mouse thymocytes were co-cultured with HEK 293 cells expressing the C57BL/6J-derived Cd274 cDNA ( Figure 5 ).
Discussion
In this paper, the use of subcongenic mouse strains has allowed us to identify a new RITL susceptibility locus mapped at the distal part of the Tlyr1 region on mouse chromosome 19 (Tlyr1c) that is involved in modulating the survival of mice with RITL. Of relevance, we found evidence of a possible epigenetic inactivation mechanism on a wide region of mouse chromosome 19, which includes Tlyr1 and neighbouring genes such as Pten and Fas, and operates during RITL development (Santos et al., 2001) . Functional polymorphisms of Fas have been also related to T-cell lymphoma susceptibility (Villa-Morales et al., 2006 . More recently, we evidenced that Anxa1, whose locus maps to the proximal part of the same Tlyr1 region, is able to confer significant resistance to g-radiation-induced thymic lymphomas (Santos et al., 2009) . Several cancer predisposition loci that independently provide susceptibility or resistance to different types of cancer have been also mapped to the chromosome interval defined by Tlyr1 (Devereux et al., 1994; Matin et al., 1999; Jawad et al., 2007) . These findings and the data reported in this study support the idea that cancer predisposition loci are organized into functional clusters containing multiple individual tumour resistance/susceptibility genes (Cormier et al., 2000; Wang et al., 2003a; Elahi et al., 2009) . In particular, Tlyr1 may be considered as a multiplex quantitative trait locus containing at least two loci with different effects on the tumour phenotype, one of them conferring RITL resistance (Tlyr1a) and the Figure 4 Co-immunoprecipitation analysis. HEK 293 cells were co-transfected with C57BL/6J-or SEG/Pas-derived Cd274-HA and Cd279-FLAG, as indicated in the text. First lane represents the genotype of C57BL/6J strain (BL/6), in which both Cd274 and Cd279 are of C57BL/6J origin; the fourth lane, however, represents the genotype of NRH3 strain, in which the global genetic background including Cd279 is of C57BL/6J origin, whereas Cd274 is SEG/Pas derived (SEG). Total lysates were immunoprecipitated (IP) using specific anti-FLAG and anti-HA antibodies, and then Cd274-HA and Cd279FLAG were detected by western Blot (WB) using anti-HA and anti-FLAG antibodies, respectively. Bands of IgGs (4150 kDa) appear because of lack of bmercaptoethanol in loading buffer. As a control for transfection, recombinant proteins Cd274-HA and Cd279FLAG were analysed in total lysates by western blot. Values under each lane indicate the intensity of each band, obtained through densitometric analysis, and normalized to the value of the loading control (IP and WB with the same antibody). As seen in the figure, the level of interaction between receptor and ligand is more than twofold in the case of the C57BL/6J strain (first lane) when compared with the NRH3 strain (fourth lane). A T-cell lymphoblastic lymphoma modifier role for Cd274 J Santos et al second one, located distally, determining RITL susceptibility (Tlyr1c).
We have considered Cd274 as a new bona fide candidate gene for the Tlyr1c region, because it is differentially expressed in the thymus stroma of 1.75 Gyg-treated C57BL/6J and NRH3 mice and is almost absent in RITL-bearing mice. Furthermore, there are qualitative differences in the Cd274 protein of C57BL/6J and NRH3 mice that affect the affinity for the Cd279 receptor, as shown by co-immunoprecipitation studies. As we did not find significant differences in the expression levels of Cd279, it is reasonable to think that the quantitative and qualitative differences observed in Cd274 should have an important role in inducing a differential function of the ligand-receptor complex of both strains. It is known that Cd274 may thus interact with Cd279 at thymocytes, triggering an inhibitory effect to modulate TCR signalling (Dong et al., 1999) . In addition, Cd279/Cd274 interactions can modify the CD4 (Nishimura et al., 2000) . Studies in Cd274 knockout mice have shown that Cd274 absence alters thymic development, increasing the number of DP thymocytes (Keir et al., 2005) . Interestingly, the expression of CD69 in thymocytes of 1.75 Gy-g-treated C57BL/6J mice was higher than in those of NRH3, indicating a differential strength in TCR signalling between these strains after g-irradiation exposure. Moreover, we found that the decrease in the thymocyte cellularity and in the number of DP cells is associated with the increase in the expression levels of Cd274 in g-treated C57BL/6J mice. These results suggest a differential control of the double-negative to DP transition between these strains, which could be attributed to a differential effect of the CD274/Cd279 interaction in the induction of the apoptotic response. In support of our hypothesis, in vitro co-culture experiments revealed that transfected HEK 293 cells expressing the C57BL/6J-Cd274 allele induce a higher rate of thymocyte apoptosis than transfected HEK 293 cells expressing the NRH3-Cd274 allele and non-transfected cells. Taken together, these data indicate that thymocytes from NRH3 mice are more resistant to g-ray-induced apoptosis than those of C57BL/6J. Consequently, T-cell lymphomas induced in NRH3 should be considered as more aggressive tumours than those induced in C57BL/ 6J. The fact that NRH3 mice showed shorter RITL latencies than those of the C57BL/6J strain seems to support this hypothesis.
Another interesting issue has to do with the stromal expression of the Cd274 antigen. Our results could be in agreement with a number of studies suggesting that stromal cells have to co-evolve with the tumoural cells per se to facilitate tumour growth (Kurose et al., 2002; Allinen et al., 2004; Pelham et al., 2006; Bian et al., 2007; Patocs et al., 2007) . In the case of haematological cells, it is well documented that lympho-stromal interactions are essential in thymic development and function (Anderson and Jenkinson, 2001 ) and that bone marrow stromal cells may contribute to prevent apoptosis of non-Hodgkin's lymphoma cells (Lwin et al., 2007) .
Furthermore, stromal gene signatures associated with survival among patients with large B-cell lymphomas have been already identified (Lenz et al., 2008) . The influence of stroma on tumour response to irradiation has been also documented (Ogawa et al., 2007) .
The CD274 antigen is known to be aberrantly overexpressed in a wide variety of human solid tumours (Dong et al., 2002; Wintterle et al., 2003; Hamanishi et al., 2007; Inman et al., 2007; Nomi et al., 2007) . In the case of human lymphomas, CD274 was found to be upregulated in T-cell lymphomas that express the anaplastic large cell lymphoma tyrosine kinase (Marzec et al., 2008 ) and Hodgkin's lymphomas (Marzec et al., 2008) . In vitro experiments using tumour cell lines evidenced that CD274 on cancer cells inhibits the cytolytic activity of cytotoxic T cells (Dong et al., 2002; Iwai et al., 2002) , implying that CD274 has a pivotal role in tumour evasion (Blank and Mackensen, 2007) . This does not seem to be the case in RITL samples, in which the expression of Cd274 was found to be scarcely perceptible in stromal cells and thymocytes from RITL-bearing mice. Thus, our findings suggest a novel protective role for the CD274/CD279 system in the control of genetic susceptibility to T-cell lymphomas, opening a new pathway to treat T-cell lymphoblastic lymphomas.
Materials and methods
Mice C57BL/6J mice were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). B6.Tlyr1 SEG congenics and mice subcongenics for SEG/Pas (Mus spretus) in the critical Tlyr1 region (NRH1-3) were generated as we described elsewhere (Burgio et al., 2007; Santos et al., 2009) . Animal experiments were carried out according to the European Commission Guidelines (Directive 86/609/CEE) on the use of laboratory animals.
Thymic lymphoma induction
Mice were exposed to whole-body fractionated (4 Â 1.75 Gy) g-irradiation at weekly doses, starting at 4 to 5 weeks of age. Treated mice were observed at weekly intervals beginning 12 weeks after completion of g-irradiation treatment and up to 25 weeks (the latency period for these tumours), and phenotyped for the presence/absence of thymic lymphomas as we previously described (Santos et al., 2002) .
Thymic cell fractionation
Thymus samples were mechanically dispersed and strained through a nylon mesh (BD Biosciences, San Jose´, CA, USA) to isolate the thymocytes. Stroma-enriched cell fractions were then obtained by collagenase digestion as previously described (Gray et al., 2002) . Stromal cells (CD45-) were afterward isolated by immunomagnetic separation using anti-CD45-conjugated paramagnetic microbeads, following the manufacture's instructions (Miltenyi Biotech, Bergisch Gladbach, Germany).
Standard RT-PCR
Transcriptional expression of the genes mapped at the Tlyr1c region was carried out using conventional RT-PCR. The SuperScript First-Strand Synthesis System (Invitrogen, Carlsbad, CA, USA) was used to perform RT-PCR reactions. The gene encoding the glucose-6-phosphate 1-dehydrogenase (G6pd) was used as an internal control. Supplementary Table  S1 shows the primer sequences used. The primers were designed by TibMolBiol (Berlin, Germany) (Supplementary Table S2 ). RT-PCR products were visualized by direct ethidium bromide staining in 1.5% agarose gels.
Quantitative real-time RT-PCR The quantification of the transcriptional levels of thymusexpressing genes was performed by real-time RT-PCR with a LightCycler instrument (Roche, Mannheim, Germany). RT-PCR reactions were carried out in total RNA using the one-step LightCycler SYBR Green I kit (Roche). The primers used were those described in Supplementary Table S2 . Relative expression values were calculated as the mRNA amount of each gene relative to that of G6pd (used as reference) and normalized to the relative expression of a non-treated thymus sample, using the LightCycler Relative Quantification software (Roche).
Western blotting
Proteins were extracted from cell lysates using TriPure Reagent (Roche), separated on 12% SDS-PAGE and electrotransferred to nitrocellulose membranes (Bio-Rad, Hercules, CA, USA). They were then incubated with anti-CD274 antibody (R&D Systems, Minneapolis, MN, USA) in a 1:100 dilution. Detection of b-actin with a monoclonal anti-b-actin antibody (Sigma, St Louis, MO, USA), in a 1:10 000 dilution, was used as control. An incubation with secondary antibodies coupled to horseradish peroxidase was next carried out using a donkey anti-goat antibody for CD274 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) in a 1:2500 dilution and a sheep anti-mouse antibody for b-actin (GE Healthcare, Waukesha, WI, USA) in a 1:10 000 dilution. Bands were detected using the enhanced chemiluminescence western blotting detection kit (GE Healthcare). Protein levels were densitometrically quantified, using the Scion Image program (Scion Corp., Frederick, MD, USA), and calculated as the amount of CD274 protein relative to that of b-actin. These were then normalized to the amount of CD274 in a non-treated thymus sample.
DNA sequencing RNA was extracted from thymuses using Tripure Reagent (Roche). On the basis of the Cd274 cDNA sequence (Genbank accession number NM_02189), a couple of primers were designed: 5 0 -CGCCTGCAGATAGTTCCCAA-3 0 (forward); 5 0 -AGGGTTCAACACTGCTTACG-3 0 (reverse). Reverse transcription was performed using the Superscript First-Strand Synthesis System (Invitrogen), followed by PCR using the Expand High Fidelity PCR System (Roche) and the aforementioned primers. cDNA sequencing reactions were performed using an ABI Prism 310 Automated Sequencer (Applied Biosystems, Foster City, CA, USA).
Immunofluorescence staining and flow cytometry analysis Freshly isolated thymocytes from non-treated and 1.75 Gy-gtreated thymuses were examined by immunofluorescence staining and flow cytometry analysis. We used fluorescein isothiocyanate-conjugated rat anti-mouse CD4 and phycoerythrin-conjugated rat anti-mouse CD8a (both from BD Pharmingen, San Diego, CA, USA) for a two-colour flow analysis of CD4-and CD8-positive cells on a FACSCalibur flow cytometer (BD Biosciences). Phycoerythrin-conjugated hamster anti-mouse CD69 (BD Pharmingen) was used for a mono-colour flow analysis of CD69-positive cells. All antibodies were used in a 1:100 dilution.
Quantification of apoptosis by TUNEL assay Cells were fixed in 3.7% formaldehyde in phosphate-buffered saline for 20 min at 4 1C and then permeabilized in 0.1% Triton X-100 sodium citrate for 5 min at 4 1C. Staining was performed in suspension cells by TUNEL assay using a commercially available kit (Roche). The percentage of TUNEL-positive cells was determined using a FACSCalibur flow cytometer.
Cloning of the Cd274 cDNA sequences To carry out transient transfection in HEK 293 cells, a couple of primers containing two distinct restriction sites for HindIII and XhoI (underlined) were designed to clone the cDNA of Cd274 into a pcDNA3 expression vector that fused the haemagglutinin epitope in frame at the 3 0 end (pcDNA3-HA, kindly gifted by Dr M Quintanilla). The primers used were: 5 0 -AAGCTTCCTGCAGATAGTTCCCAAAA-3 0 (Cd274-HindIIIforward) and 5 0 -CTCGAGTCCCGTCTCCTCGAATTGTG-3 0 (Cd274XhoI-reverse). C57BL/6J-and SEG/Pas-derived thymus RNAs were reverse transcribed using SuperScript FirstStrand Synthesis System for RT-PCR (Invitrogen) followed by PCR using the Expand High Fidelity PCR System and the aforementioned primers. Conditions for PCR were as indicated by the manufacturer, with an annealing temperature of 58.8 1C, and an elongation time of 60 s. Purified DNA fragments containing the Cd274 cDNA were cloned into pGEM-T Easy Vector (Promega, Madison, WI, USA) as described previously. Fragments doubly digested with HindIII and XhoI (Roche) were subcloned into pcDNA3-HA plasmid.
To perform stable transfections in HEK 293 cells, the cDNAs of Cd274 were cloned into a pcDNA3 expression vector following the same protocol. The primers used were: 5 0 -AAGCTTCGCCTGCAGATAGTTCCCAA-3 0 (Cd274-FHindIII) and 5 0 -CTCGAGAGGGTTCAACACTGCTTACG -3 0 (Cd274-R-XhoI). Primer designs were based on the previously reported sequences for Cd274 cDNA (Genbank accession number NM_02189).
Cloning of the Cd279 receptor cDNA sequences A similar protocol was followed to clone Cd279 cDNA in frame into a pcDNA3-Flag vector. On the basis of the previously reported sequence for the Cd279 receptor cDNA (Genbank accession number NM_0087989), the following primers were designed: 5 0 -AAGCTTGCTACTGAAGGCGA CACTGC-3 0 (Cd279-HindIII-forward) and 5 0 -CTCGAGTCC AAGAGGCCAAGAACAAT-3 0 (Cd279-XhoI-reverse). C57BL/ 6J-and SEG/Pas-derived thymus RNAs were reverse transcribed using SuperScript First-Strand Synthesis System for RT-PCR (Invitrogen), followed by PCR using the Expand High Fidelity PCR System and the aforementioned primers. Conditions for PCR were as indicated by the manufacturer, with an annealing temperature of 60.9 1C, and an elongation time of 60 s. Purified DNA fragments containing the Pdcd1 cDNA were cloned into pGEM-T Easy Vector (Promega) as described previously. Fragments doubly digested with HindIII and XhoI (Roche) were subcloned into pcDNA3-Flag plasmid (gifted by Dr M Quintanilla).
Transient transfection of HEK 293 cells and co-immunoprecipitation experiments
HEK 293 cells were transiently co-transfected with combinations of Cd274-HA and Cd279-Flag in pcDNA3 expression vectors using Lipofectamine reagent (Invitrogen). Cells were lysed 24 h after transfection and protein expression determined by western blotting or co-immunoprecipitation. For immunoprecipitation experiments, cells were lysed in IPH buffer (0.5% Igepal CA-630 (formerly NP-40), 150 mM NaCl, 5 mM EDTA and 50 mM Tris-HCl pH 8) and a cocktail of protease inhibitors: 2 mM phenylmethylsulphonyl fluoride, 2.5 ml/ml protease inhibitor cocktail and 10 ml/ml phosphatase inhibitor cocktail 2 (Roche). Tagged CD274 and CD279 proteins were immunoprecipitated using anti-HA (clone 3F10; Roche) or anti-Flag (Sigma-Aldrich, Munich, Germany) monoclonal antibodies. Rabbit anti-rat or anti-mouse immunoglobulin Gs (Jackson Immunoresearch, West Grove, PA, USA) coupled to protein A-Sepharose (Sigma-Aldrich) were used as secondary antibodies. Detection of co-precipitated proteins in western blots was performed with anti-HA and anti-Flag monoclonal antibodies, and appropriate secondary antibodies: Immunopure Goat Anti-Rat immunoglobulin G, (H þ L), peroxidase conjugated (Thermo Scientific, Pittsburgh, PA, USA; Pierce Biotechnology, West Grove, PA, USA); enhanced chemiluminescence mouse immunoglobulin G, horseradish peroxidase-linked whole antibody (from sheep) NXA931 (GE Healthcare, Boston, MA, USA).
Stable transfection of HEK 293 cells and co-cultures HEK293 cells were stably transfected with C57BL/6J-and SEG/Pas-derived Cd274 in pcDNA3 expression vectors using 30.5 mM CaCl2. Cells were flushed with CO2 and placed at 37 1C, and once the cells had completely recovered and grown to confluence, they were trypsinized and reseeded with a 1/10 dilution. At this point, these cells were put under selection with G418 (500 mg/ml) for 2 weeks and refreshed twice a week. Once cellular colonies had grown enough, they were transferred into a 24-well format, and tested by quantitative real-time RT-PCR and immunofluorescence staining using anti-CD274 antibody (R&D Systems) and Alexa Fluor 488 rabbit antigoat (Molecular Probes, Eugene, OR, USA). Freshly isolated mouse thymocytes (2.5 Â 10 6 ) were co-cultured with stably transfected and non-transfected HEK293 (2.5 Â 10 6 ) for 24 h. Both cells types were removed together to be fixed and stained by TUNEL assay to quantify apoptosis.
Statistical analysis
Curves for association of mouse strains with RITL latency were generated using the Kaplan-Meier method, and log-rank statistic test was performed for comparison of the curves between groups using the SPSS software, version 15.0 (SPSS Inc., Chicago, IL, USA). The one-way or two-way analysis of variance was applied for multiple comparisons. These statistical tests were carried out using the R software (R version 27.1) (R Foundation for Statistical Computing, Vienna, Austria).
